Stock listing

Lang & Schwarz:A40D1S BioCardia, Inc. Aktie

German listing (Lang & Schwarz) of BioCardia, Inc. · home listing NASDAQ:BCDA

Follow BioCardia, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:BCDA

$0.785 USD +0.013 (+1.7%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:BCDA

Past year -38.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.720 – $0.799 USDNov 20, 2026
Volume
350,429 sharesNov 20, 2026
Market cap
$11.88M USDAt the close on Nov 20, 2026 · price × 15.14M shares outstanding
52-week range
$0.661 – $1.800 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$217,942 USDMedian day 129,616 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
BioCardia, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:BCDA · Home$0.785 USD+0.013 (+1.7%)350,429$0.749$0.799$0.720$0.772Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:BCDA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.785+0.013+1.7%$0.749$0.799$0.720350,429
$0.772-0.016-2.1%$0.849$0.849$0.76022,925
$0.788-0.002-0.2%$0.763$0.800$0.74941,869
$0.790-0.041-4.9%$0.837$0.850$0.75160,744
$0.831+0.005+0.6%$0.970$0.970$0.81578,300
$0.826-0.096-10.4%$0.950$0.950$0.661287,877
$0.922-0.009-0.9%$0.927$0.980$0.91058,184
$0.930+0.028+3.1%$0.900$0.965$0.90036,847
$0.903+0.053+6.2%$0.890$0.960$0.850117,698
$0.850-0.040-4.5%$0.930$0.930$0.850167,664
$0.890-0.023-2.5%$0.892$0.910$0.840136,810
$0.913-0.008-0.9%$0.970$0.970$0.884110,558
$0.922+0.020+2.2%$0.936$0.978$0.90370,085
$0.902+0.041+4.8%$0.868$1.000$0.86081,691
$0.861-0.065-7.0%$0.920$0.920$0.86178,713
$0.926-0.021-2.3%$0.963$1.000$0.92647,056
$0.947+0.026+2.8%$0.935$0.947$0.92219,925
$0.922+0.020+2.2%$0.900$0.928$0.87037,114
$0.902-0.020-2.1%$0.921$0.929$0.870129,616
$0.921-0.008-0.8%$0.948$0.950$0.91240,315
$0.929-0.054-5.5%$0.976$0.986$0.92050,139
$0.982-0.058-5.5%$1.050$1.050$0.970133,411
$1.040+0.143+15.9%$0.900$1.070$0.900217,707
$0.898-0.023-2.4%$0.900$1.020$0.881439,732
$0.920-0.020-2.1%$0.950$0.960$0.910104,800
$0.940+0.010+1.1%$0.940$0.970$0.870236,300
$0.930-0.060-6.1%$1.000$1.000$0.910146,400
$0.990-0.030-2.9%$1.020$1.030$0.98068,000
$1.020-0.020-1.9%$1.040$1.040$1.00080,300
$1.040-0.020-1.9%$1.060$1.080$1.020101,900
$1.060-0.030-2.8%$1.070$1.090$1.050162,400
$1.090+0.030+2.8%$1.070$1.090$1.030167,800
$1.060-0.030-2.8%$1.100$1.110$1.050113,400
$1.090+0.050+4.8%$1.060$1.090$1.040148,400
$1.040+0.020+2.0%$1.040$1.050$1.03052,500
$1.020+0.010+1.0%$1.000$1.050$0.990205,900
$1.010-0.020-1.9%$1.040$1.040$1.01090,700
$1.030-0.010-1.0%$1.050$1.070$1.000117,300
$1.040-0.010-1.0%$1.050$1.090$1.040159,200
$1.050-0.020-1.9%$1.080$1.080$1.05051,200
$1.070+0.020+1.9%$1.030$1.090$1.030122,500
$1.0500.0000.0%$1.030$1.080$1.030141,000
$1.050-0.030-2.8%$1.030$1.100$0.980497,400
$1.080-0.090-7.7%$1.180$1.190$1.0602,080,400
$1.170+0.060+5.4%$1.120$1.210$1.100169,900
$1.110-0.140-11.2%$1.250$1.260$1.100416,300
$1.250+0.020+1.6%$1.240$1.400$1.1301,529,300
$1.230+0.040+3.4%$1.190$1.290$1.190518,700
$1.190+0.110+10.2%$1.100$1.230$1.100595,100
$1.080-0.020-1.8%$1.120$1.140$1.080137,000
$1.1000.0000.0%$1.090$1.110$1.07080,000
$1.100-0.010-0.9%$1.110$1.140$1.09091,000
$1.110+0.030+2.8%$1.090$1.140$1.080130,300
$1.080-0.010-0.9%$1.070$1.090$1.06057,300
$1.090-0.020-1.8%$1.120$1.130$1.070168,500
$1.110+0.010+0.9%$1.110$1.130$1.10051,000
$1.100-0.040-3.5%$1.130$1.130$1.08068,500
$1.140-0.010-0.9%$1.140$1.170$1.100141,700
$1.150-0.020-1.7%$1.170$1.200$1.110159,000
$1.170-0.020-1.7%$1.180$1.230$1.170211,600
$1.190+0.060+5.3%$1.130$1.210$1.100244,500
$1.130+0.070+6.6%$1.060$1.140$1.020354,000
$1.060+0.050+5.0%$1.000$1.060$0.980272,400
$1.010+0.040+4.1%$0.970$1.020$0.96082,500
$0.970-0.020-2.0%$1.000$1.000$0.950156,200

Splits

6 splits since 2001 · NASDAQ:BCDA · every price before a split is adjusted for it

DayRatioWhat
1-for-15Consolidation
1-for-9Consolidation
1-for-12Consolidation
1-for-10Consolidation
6-for-1Split
1-for-3Consolidation
Ticker
Lang & Schwarz:A40D1S
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Latest news

All BioCardia, Inc. news

BioCardia, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
35 in the last 12 months · 188 in all · newest Nov 12, 2026 · oldest 2019
Calls
20 calls with a replay · 20 with a transcript · latest Nov 12, 2026
Decks
18 decks · latest November 2026

Where BioCardia, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:BCDA · Home listingNASDAQUnited StatesUSD
BOATS:BCDABOATSUnited StatesUSD
Frankfurt:6JU0FrankfurtGermanyEUR
gettex:6JU0gettexGermanyEUR
Lang & Schwarz:A40D1S · This pageLang & SchwarzGermanyEUR

Valuation

Price/book 14.2× against a median of 2.0×: 6th lowest of 8 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$10.22M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
14.2×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.7×
Beta vs S&P 500
0.42

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
BioCardia, Inc. · NASDAQ:BCDAUS$11.88MUS$10.22Mn/an/an/a14.2×n/a0.7×0.42
MIRA Pharmaceuticals, Inc. · NASDAQ:MIRAUS$12.23MUS$5.26Mn/an/an/a1.8×n/a0.0×1.48
Genflow Biosciences PLC · LSE:GENFUS$12.06MUS$11.23Mn/an/an/a48.5×n/a0.0×n/a
Xintela AB · OMXSTO:XINTUS$11.88MUS$11.81Mn/a39.8×n/an/an/an/an/a
Pluri Inc. · NASDAQ:PLURUS$11.85MUS$38.65Mn/a26.5×n/an/an/an/a0.53
Synlogic Inc · OTC:SYBXUS$11.76MUS$201,442n/an/an/a1.2×n/a0.0×0.50
Imugene Ltd · ASX:IMUUS$11.74MUS$14.16Mn/an/an/a2.0×n/a0.7×n/a
Radiopharm Theranostics Limited · ASX:RADUS$11.59MUS$8.85Mn/a4.8×n/a0.7×n/a0.0×n/a
Aelis Farma SA · EURONEXT:AELISUS$11.55MUS$9.09Mn/a4.0×n/a4.5×−308.7%1.9×n/a
Simris Group AB Class B · OMXSTO:SIMRIS_BUS$11.54MUS$19.53Mn/a144×n/a154×n/a117×n/a
Dyadic International, Inc. · NASDAQ:DYAIUS$11.51MUS$12.03Mn/a3.9×n/an/a−226.9%n/a1.12
Median of the othersUS$11.75MUS$11.52M15.7×2.0×−267.8%0.0×0.83

Forecasts

2 strong buy · Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.

Price target
15.50 USD · Analysts' mean
EPS, year to Dec 2026
-0.63 · 1 analyst

Team and board

Officers

OfficerRole
Peter AltmanPresident and Chief Executive Officer
David McClungCFO
Bill FacteauPresident
Miranda PetoInvestor Relations
Debby Holmes-HigginVP of Clinical
Edward GillisSr. VP of Devices

Board

DirectorRole
Andrew Scott BlankChairman of our board of directors
Jay M. MoyesBoard Member
Marvin SlosmanBoard Member
Peter AltmanPresident and Chief Executive Officer
Simon H. StertzerBoard Member

Events

Calls

CallWhenStatus
BioCardia (NASDAQ:BCDA) Q3 2026 Earnings CallThu, Nov 12, 2026 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q2 2026 Earnings CallWed, Aug 12, 2026 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q1 2026 Earnings CallFri, May 15, 2026 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q4 2025 Earnings CallTue, Mar 24, 2026 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q3 2025 Earnings CallWed, Nov 12, 2025 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q2 2025 Earnings CallMon, Aug 11, 2025 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q1 2025 Earnings CallWed, May 14, 2025 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q4 2024 Earnings CallMon, Mar 31, 2025 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q3 2024 Earnings CallWed, Nov 13, 2024 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q2 2024 Earnings CallTue, Aug 13, 2024 · 4:30 PM ETReplay
All 20 calls
CallWhenStatus
BioCardia (NASDAQ:BCDA) Q1 2024 Earnings CallTue, May 14, 2024 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q4 2023 Earnings CallWed, Mar 27, 2024 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q3 2023 Earnings CallWed, Nov 08, 2023 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q2 2023 Earnings CallWed, Aug 09, 2023 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q1 2023 Earnings CallWed, May 10, 2023 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q4 2022 Earnings CallWed, Mar 29, 2023 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q3 2022 Earnings CallWed, Nov 09, 2022 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q2 2022 Earnings CallWed, Aug 10, 2022 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q1 2022 Earnings CallWed, May 11, 2022 · 4:30 PM ETReplay
BioCardia (NASDAQ:BCDA) Q4 2021 Earnings CallTue, Mar 29, 2022 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 12, 2026 · After close+0.6%
Q2 2026Aug 12, 2026 · After close+5.7%
Q1 2026May 15, 2026−17.4%
Q4 2025Mar 24, 2026 · After close−0.4%
Q3 2025Nov 12, 2025 · After close−3.1%
Q2 2025Aug 11, 2025 · Before open−6.2%
Q1 2025May 14, 2025 · After close−16.3%
Q4 2024Mar 25, 2025 · Before open+1.1%
Q3 2024Nov 13, 2024 · After close−14.3%
Q2 2024Aug 13, 2024 · After close−1.9%
All 20 quarters
QuarterResultsShare move
Q1 2024May 14, 2024 · After close+1.0%
Q4 2023Mar 27, 2024 · After close−2.9%
Q3 2023Nov 8, 2023 · After close−5.8%
Q2 2023Aug 9, 2023 · After close−0.4%
Q1 2023May 10, 2023 · After close+0.5%
Q4 2022Mar 29, 2023 · Before open−4.6%
Q3 2022Nov 9, 2022 · After close−3.0%
Q2 2022Aug 10, 2022 · After close+5.3%
Q1 2022May 11, 2022 · After close+11.9%
Q4 2021Mar 29, 2022 · After close−2.4%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck23 slidesNovember 2026
Investor Presentation (August 2026)Investor deck24 slidesAugust 2026
Q1 2026 Earnings PresentationEarnings19 slidesMay 15, 2026
Technical Presentation (April 2026)Technical36 slidesApr 28, 2026
Q4 2025 Earnings PresentationEarnings22 slidesMar 24, 2026
Investor Presentation (September 2025)Investor deck35 slidesSeptember 2025
Q1 2025 Earnings PresentationEarnings38 slidesMay 14, 2025
Investor Presentation (March 2025)Investor deck31 slidesMarch 2025
Investor Presentation (November 2024)Investor deck24 slidesNovember 2024
Technical Presentation (April 2024)Technical13 slidesApr 30, 2024
All 18 decks
DeckKindSlidesDate
Investor Presentation (March 2024)Investor deck27 slidesMarch 2024
Next Generation Cardiovascular Drug Development Summit (April 2023)Conference24 slidesApr 28, 2023
Investor Presentation (March 2023)Investor deck21 slidesMar 29, 2023
Investor Presentation (June 2021)Investor deck27 slidesJune 2021
Forum for Innovative Regenerative Medicine, Regenerative Medicine Cross Roads (January 2019)Conference27 slidesJan 28, 2019
Technical Presentation (November 2018)Technical12 slidesNov 14, 2018
ARM Partnering Presentation (October 2015)Conference17 slidesOct 7, 2015
IPO Roadshow (October 2015)IPO roadshow17 slidesOct 6, 2015

Open Decks

Financings

RaiseDate
Public offering of common stock and short-term warrants
Announced: US$6M · US$1.25 a share · Warrants at US$1.25 for 24 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and general corporate purposes, including advancing biotherapeutic candidates and the delivery partnering business
Sep 18, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue058.0K477.0K1.35M1.01M145.0K710.0K625.0K479.0K576.0K
Cost of revenue505.0K4.39M7.73M11.9M04.00K358.0K517.0K690.0K746.0K
Gross profit-505.0K-4.33M-7.25M-10.5M375.0K141.0K352.0K108.0K-211.0K-170.0K
Research and development4.96M4.39M7.73M8.83M8.56M9.81M8.56M8.45M5.80M3.33M
Selling, general and administrative3.32M3.67M4.39M4.42M5.09M5.86M6.00M5.76M6.39M4.11M
Operating income-8.28M-8.00M-11.6M-11.9M-12.6M-15.5M-14.2M-14.1M-12.4M-7.61M
Depreciation and amortization24.0K67.0K84.0K82.0K60.0K68.0K111.0K88.0K78.0K39.0K
EBITDA-8.25M-7.93M-11.6M-11.8M-12.6M-15.5M-14.1M-14.0M-12.3M-7.57M
Interest expense6.00K03.00K112.0K118.0K01.74M
Income before tax-8.23M-7.95M-11.6M-11.9M-12.6M-15.0M-14.7M-14.0M-12.3M-10.3M
Income tax0000000000
Net income-8.23M-7.95M-11.6M-11.9M-12.6M-15.0M-14.7M-14.0M-12.3M-10.3M
Earnings per share, basic-1.23-2.90-8.19-0.67-0.75-1.48-2.61-3.28-2.90-1.23
Earnings per share, diluted-0.75-1.48-2.61-3.28-2.90-1.23

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents2.50M2.37M1.10M7.36M12.9M21.4M5.58M5.36M12.7M21.4M
Receivables20.0K063.0K201.0K147.0K232.0K147.0K274.0K95.0K74.0K
Inventory-201.0K1-850.0K4.00K141.0K191.0K135.0K
Current assets2.73M2.62M1.46M7.86M13.5M22.7M6.38M6.22M13.3M21.9M
Property, plant and equipment16.0K33.0K94.0K170.0K182.0K145.0K181.0K145.0K169.0K111.0K
Total assets3.41M3.72M2.99M9.79M15.7M23.4M7.68M6.42M13.5M22.1M
Accounts payable641.0K385.0K890.0K683.0K507.0K746.0K914.0K743.0K902.0K525.0K
Current liabilities2.43M2.32M3.61M3.58M3.71M4.25M4.00M2.55M2.33M1.44M
Total debt528.0K951.0K1.31M1.63M1.87M614.0K1.14M
Total liabilities2.52M2.89M4.59M4.90M5.34M4.25M5.31M2.63M2.41M1.50M
Shareholders' equity895.0K837.0K-1.60M4.89M10.4M19.2M2.37M3.79M11.1M20.6M
Shares outstanding10.8M4.60M1.58M20.1M16.9M16.3M6.83M4.85M38.2M38.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-7.44M-7.89M-9.97M-10.6M-10.4M-12.4M-9.45M-11.1M-8.67M-5.52M
Capital spending-7.00K-6.00K-12.0K-70.0K-116.0K-32.0K-146.0K-66.0K-136.0K-136.0K
Free cash flow-7.44M-7.89M-9.99M-10.6M-10.5M-12.4M-9.59M-11.1M-8.81M-5.52M
Cash from investing-7.00K-6.00K-12.0K-70.0K-116.0K-32.0K-146.0K-66.0K-136.0K18.9M
Cash from financing7.57M9.16M3.73M5.12M1.95M28.2M9.82M3.80M144.0K4.40M
Dividends paid-346.0K
Share buybacks-160.0K9.19M3.80M144.0K4.40M
Change in cash125.0K1.27M-6.26M-5.51M-8.54M15.8M227.0K-7.33M-8.66M17.8M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 20, 2026Current reportSEC
8-K · Current reportNov 12, 2026ResultsSEC
10-Q · Quarterly reportNov 12, 2026Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 10, 2026Big-stake noticeSEC
8-K · Current reportNov 6, 2026Current reportSEC
4 · Change in ownershipOct 20, 2026Insider tradeSEC
8-K · Current reportOct 19, 2026Current reportSEC
8-K · Current reportOct 7, 2026Current reportSEC
8-K · Current reportOct 1, 2026Current reportSEC
4 · Change in ownershipSep 30, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipSep 23, 2026Insider tradeSEC
8-K · Current reportSep 23, 2026Current reportSEC
8-K · Current reportSep 21, 2026Current reportSEC
8-K · Current reportSep 10, 2026Current reportSEC
4 · Change in ownershipSep 4, 2026Insider tradeSEC
8-K · Current reportAug 24, 2026Current reportSEC
8-K · Current reportAug 21, 2026Current reportSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 13, 2026Insider tradeSEC
8-K · Current reportAug 12, 2026ResultsSEC
10-Q · Quarterly reportAug 12, 2026Quarterly reportSEC
4 · Change in ownershipJul 29, 2026Insider tradeSEC
4 · Change in ownershipJul 20, 2026Insider tradeSEC
4 · Change in ownershipJul 15, 2026Insider tradeSEC
4 · Change in ownershipJul 10, 2026Insider tradeSEC
4 · Change in ownershipJul 8, 2026Insider tradeSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
4 · Change in ownershipJun 24, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
8-K · Current reportJun 18, 2026Current reportSEC
8-K · Current reportJun 12, 2026Current reportSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
8-K · Current reportJun 8, 2026Current reportSEC
8-K · Current reportJun 5, 2026Current reportSEC
8-K · Current reportMay 28, 2026Current reportSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
8-K · Current reportMay 21, 2026Current reportSEC
4 · Change in ownershipMay 18, 2026Insider tradeSEC
4 · Change in ownershipMay 15, 2026Insider tradeSEC
8-K · Current reportMay 15, 2026ResultsSEC
10-Q · Quarterly reportMay 15, 2026Quarterly reportSEC
8-K · Current reportMay 8, 2026Current reportSEC
4 · Change in ownershipApr 29, 2026Insider tradeSEC
8-K · Current reportApr 28, 2026Current reportSEC
4 · Change in ownershipApr 22, 2026Insider tradeSEC
8-K · Current reportApr 20, 2026Current reportSEC
8-K · Current reportApr 15, 2026Current reportSEC
8-K · Current reportApr 2, 2026Current reportSEC
4 · Change in ownershipMar 26, 2026Insider tradeSEC
8-K · Current reportMar 24, 2026ResultsSEC
S-8 · Registration statement for employee plansMar 24, 2026Offer documentSEC
10-K · Annual reportMar 24, 2026Annual reportSEC
8-K · Current reportMar 17, 2026Current reportSEC
8-K · Current reportMar 3, 2026Current reportSEC
8-K · Current reportFeb 10, 2026Current reportSEC
4 · Change in ownershipFeb 4, 2026Insider tradeSEC
8-K · Current reportFeb 3, 2026Current reportSEC
4 · Change in ownershipJan 21, 2026Insider tradeSEC
S-8 · Registration statement for employee plansDec 18, 2025Offer documentSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
8-K · Current reportDec 16, 2025Current reportSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
3 · Initial statement of ownershipDec 10, 2025Insider tradeSEC
8-K · Current reportDec 3, 2025Management or board changeSEC
8-K · Current reportNov 24, 2025Current reportSEC
8-K · Current reportNov 12, 2025ResultsSEC
10-Q · Quarterly reportNov 12, 2025Quarterly reportSEC
8-K · Current reportNov 10, 2025Current reportSEC
DEF 14A · Proxy statementNov 3, 2025Meeting noticeSEC
8-K · Current reportOct 30, 2025Current reportSEC
10-Q/A · Quarterly report, amendedOct 29, 2025Quarterly reportSEC
424B5 · ProspectusOct 24, 2025Offer documentSEC
8-K · Current reportOct 7, 2025Current reportSEC
8-K · Current reportOct 2, 2025Current reportSEC
SCHEDULE 13G · Big-stake noticeSep 24, 2025Big-stake noticeSEC
8-K · Current reportSep 24, 2025Current reportSEC
4 · Change in ownershipSep 23, 2025Insider tradeSEC
4 · Change in ownershipSep 23, 2025Insider tradeSEC
4 · Change in ownershipSep 23, 2025Insider tradeSEC
8-K · Current reportSep 22, 2025Current reportSEC
SCHEDULE 13G · Big-stake noticeSep 19, 2025Big-stake noticeSEC
8-K · Current reportSep 19, 2025Current reportSEC
424B4 · ProspectusSep 19, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveSep 19, 2025Other filingsSEC
8-K · Current reportSep 18, 2025Current reportSEC
8-K · Current reportSep 18, 2025Current reportSEC
CORRESP · Letter to the SECSep 17, 2025Other filingsSEC
S-1/A · Registration statement, amendedSep 17, 2025Offer documentSEC
CORRESP · Letter to the SECSep 16, 2025Other filingsSEC
S-1 · Registration statementSep 16, 2025Offer documentSEC
4 · Change in ownershipAug 25, 2025Insider tradeSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 13, 2025Big-stake noticeSEC
8-K · Current reportAug 13, 2025Current reportSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
4 · Change in ownershipAug 11, 2025Insider tradeSEC
10-Q · Quarterly reportAug 11, 2025Quarterly reportSEC
8-K · Current reportAug 11, 2025ResultsSEC
8-K · Current reportAug 4, 2025Current reportSEC
8-K · Current reportJul 24, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveJul 18, 2025Other filingsSEC
EFFECT · Notice that a registration is effectiveJul 18, 2025Other filingsSEC
8-K · Current reportJul 16, 2025Current reportSEC
CORRESP · Letter to the SECJul 15, 2025Other filingsSEC
CORRESP · Letter to the SECJul 15, 2025Other filingsSEC
UPLOAD · Letter from the SECJul 14, 2025Other filingsSEC
S-3 · Registration statementJul 9, 2025Offer documentSEC
424B5 · ProspectusJul 8, 2025Offer documentSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
8-K · Current reportJul 2, 2025FinancingSEC
8-K · Current reportJun 25, 2025Current reportSEC
4 · Change in ownershipMay 30, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
SCHEDULE 13D · Big-stake noticeMay 22, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMay 21, 2025Big-stake noticeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
8-K · Current reportMay 14, 2025ResultsSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
8-K · Current reportMay 6, 2025Current reportSEC
UPLOAD · Letter from the SECMay 5, 2025Other filingsSEC
8-K · Current reportMay 1, 2025Current reportSEC
S-3 · Registration statementApr 30, 2025Offer documentSEC
4 · Change in ownershipApr 28, 2025Insider tradeSEC
4 · Change in ownershipApr 25, 2025Insider tradeSEC
4 · Change in ownershipApr 25, 2025Insider tradeSEC
4 · Change in ownershipApr 25, 2025Insider tradeSEC
4 · Change in ownershipApr 25, 2025Insider tradeSEC
4 · Change in ownershipApr 25, 2025Insider tradeSEC
8-K · Current reportApr 23, 2025FinancingSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
8-K · Current reportApr 15, 2025Current reportSEC
4 · Change in ownershipApr 14, 2025Insider tradeSEC
8-K · Current reportApr 11, 2025Current reportSEC
4 · Change in ownershipApr 8, 2025Insider tradeSEC
4 · Change in ownershipApr 7, 2025Insider tradeSEC
4 · Change in ownershipApr 4, 2025Insider tradeSEC
424B5 · ProspectusApr 4, 2025Offer documentSEC
8-K · Current reportApr 4, 2025Current reportSEC
4 · Change in ownershipApr 3, 2025Insider tradeSEC
8-K · Current reportMar 31, 2025Current reportSEC
8-K · Current reportMar 31, 2025Current reportSEC
S-8 · Registration statement for employee plansMar 26, 2025Offer documentSEC
8-K · Current reportMar 26, 2025ResultsSEC
10-K · Annual reportMar 26, 2025Annual reportSEC
UPLOAD · Letter from the SECMar 20, 2025Other filingsSEC
DRS · Draft registration statementMar 17, 2025Offer documentSEC
8-K · Current reportMar 10, 2025Current reportSEC
4 · Change in ownershipMar 7, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
8-K · Current reportFeb 27, 2025Current reportSEC
8-K · Current reportFeb 13, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 12, 2025Big-stake noticeSEC
4 · Change in ownershipFeb 11, 2025Insider tradeSEC
4 · Change in ownershipJan 30, 2025Insider tradeSEC
8-K · Current reportJan 27, 2025Current reportSEC
4 · Change in ownershipDec 26, 2024Insider tradeSEC
4 · Change in ownershipDec 26, 2024Insider tradeSEC
144 · Notice of proposed saleDec 17, 2024Other filingsSEC
8-K · Current reportDec 17, 2024Current reportSEC
4 · Change in ownershipDec 9, 2024Insider tradeSEC
8-K · Current reportDec 4, 2024Current reportSEC
424B5 · ProspectusDec 2, 2024Offer documentSEC
4 · Change in ownershipNov 19, 2024Insider tradeSEC
8-K · Current reportNov 13, 2024ResultsSEC
10-Q · Quarterly reportNov 13, 2024Quarterly reportSEC
8-K · Current reportOct 28, 2024Current reportSEC
4 · Change in ownershipOct 16, 2024Insider tradeSEC
4 · Change in ownershipOct 16, 2024Insider tradeSEC
4 · Change in ownershipOct 16, 2024Insider tradeSEC
4 · Change in ownershipOct 16, 2024Insider tradeSEC
4 · Change in ownershipOct 16, 2024Insider tradeSEC
4 · Change in ownershipOct 16, 2024Insider tradeSEC
4 · Change in ownershipOct 16, 2024Insider tradeSEC
4 · Change in ownershipOct 16, 2024Insider tradeSEC
4 · Change in ownershipOct 16, 2024Insider tradeSEC
8-K · Current reportSep 18, 2024Current reportSEC
8-K · Current reportSep 9, 2024Current reportSEC

This page holds 200 of 1,002 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from BioCardia, Inc.’s releases · as of Nov 11, 2026

Common shares
15,138,782
Fully diluted
15,138,782

Fully diluted

LineSharesAs of
Common shares15,138,782Nov 11, 2026

Share count over time

CountShares
Nov 11, 202615,138,782

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
CM Management, LLC400K2.6%US$404KSep 30, 2026
Citigroup Inc275K1.8%US$278KSep 30, 2026
Vanguard191K1.3%US$193KSep 30, 2026
Pingora Partners LLC160K1.1%US$161KSep 30, 2026
Geode Capital105K0.69%US$106KSep 30, 2026
Gsa Capital Partners LLP54,7560.36%US$55,000Sep 30, 2026
Brown Advisory Inc48,7380.32%US$49,225Sep 30, 2026
Hrt Financial LP44,9490.30%US$45,000Sep 30, 2026
Susquehanna38,8170.26%US$39,205Sep 30, 2026
StoneX Group Inc.33,4450.22%US$32,937Sep 30, 2026
All 20 holders
HolderSharesOf the companyValueAs of
Virtu Financial LLC24,1420.16%US$24,000Sep 30, 2026
Wealth Enhancement Advisory Services, LLC18,5000.12%US$19,610Sep 30, 2026
Citadel16,6910.11%US$16,858Sep 30, 2026
Commonwealth Equity Services, LLC13,3830.09%US$13,520Sep 30, 2026
Tower Research Capital LLC (TRC)3,9430.03%US$3,982Sep 30, 2026
Morgan Stanley3,1050.02%US$3,136Sep 30, 2026
UBS1,010<0.01%US$1,020Sep 30, 2026
Global Retirement Partners, LLC411<0.01%US$415Sep 30, 2026
SBI Securities Co., Ltd.15<0.01%US$15Sep 30, 2026
Caitong International Asset Management Co., Ltd8<0.01%US$8Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Extended Market Index Fund69,0230.46%US$85,589Jun 30, 2026
Fidelity Extended Market Index Fund59,9710.40%US$55,773May 31, 2026
Vanguard Total Stock Market Index Fund55,5680.37%US$68,904Jun 30, 2026
Fidelity Series Total Market Index Fund10,5260.07%US$9,789May 31, 2026
Fidelity Total Market Index Fund3,2370.02%US$3,010May 31, 2026
Fidelity Nasdaq Composite Index Fund964<0.01%US$897May 31, 2026
Blackstone Alternative Multi-Strategy Fund47<0.01%US$58Jun 30, 2026

Insider trades

TradeTradeSharesPriceValueDate
Altman Peter
Director, Officer: President and CEO
Buy300USD 0.95US$285Oct 16, 2026
Altman Peter
Director, Officer: President and CEO
Buy200USD 0.95US$190Oct 15, 2026
Altman Peter
Director, Officer: President and CEO
Buy1,000USD 1.03US$1,030Sep 29, 2026
Altman Peter
Director, Officer: President and CEO
Buy1,900USD 1.05US$1,995Sep 23, 2026
Altman Peter
Director, Officer: President and CEO
Buy800USD 1.09US$872Sep 3, 2026
Altman Peter
Director, Officer: President and CEO
Buy5,400USD 0.93US$5,022Aug 17, 2026
Altman Peter
Director, Officer: President and CEO
Buy1,900USD 0.92US$1,748Aug 13, 2026
Altman Peter
Director, Officer: President and CEO
Buy5,000USD 0.78US$3,900Jul 29, 2026
Altman Peter
Director, Officer: President and CEO
Buy500USD 0.83US$415Jul 17, 2026
Altman Peter
Director, Officer: President and CEO
Buy1,500USD 0.86US$1,290Jul 15, 2026
All 27 trades
TradeTradeSharesPriceValueDate
Altman Peter
Director, Officer: President and CEO
Buy2,800USD 0.88US$2,464Jul 14, 2026
Altman Peter
Director, Officer: President and CEO
Buy1,000USD 0.94US$940Jul 10, 2026
Altman Peter
Director, Officer: President and CEO
Buy1,000USD 0.90US$900Jul 9, 2026
Altman Peter
Director, Officer: President and CEO
Buy5,500USD 0.97US$5,335Jul 8, 2026
Altman Peter
Director, Officer: President and CEO
Buy5,400USD 0.96US$5,184Jul 8, 2026
Stertzer Simon H
Director
Buy39,000USD 1.00US$39,000Jun 23, 2026
Stertzer Simon H
Director
Buy70,200USD 0.92US$64,584Jun 22, 2026
Altman Peter
Director, Officer: President and CEO
Buy800USD 0.96US$768Jun 18, 2026
Altman Peter
Director, Officer: President and CEO
Buy1,500USD 0.85US$1,275Jun 17, 2026
Altman Peter
Director, Officer: President and CEO
Buy5,000USD 0.85US$4,250Jun 9, 2026
Altman Peter
Director, Officer: President and CEO
Buy1,500USD 0.92US$1,380May 20, 2026
Altman Peter
Director, Officer: President and CEO
Buy200USD 0.95US$190May 19, 2026
Altman Peter
Director, Officer: President and CEO
Buy5,700USD 0.92US$5,244May 18, 2026
Altman Peter
Director, Officer: President and CEO
Buy5,100USD 1.02US$5,202May 15, 2026
Altman Peter
Director, Officer: President and CEO
Buy5,000USD 1.11US$5,550Apr 29, 2026
Altman Peter
Director, Officer: President and CEO
Buy400USD 1.23US$492Apr 21, 2026
Altman Peter
Director, Officer: President and CEO
Buy600USD 1.23US$738Apr 20, 2026

Big stakes

StakeStakeSharesDateFiling
Thomas A. Satterfield, Jr.9.90%1.54MSep 30, 2026Schedule 13G
Lincoln Alternative Strategies LLC7.54%800KSep 19, 2025Schedule 13G
Blank Andrew Scott5.50%278KApr 23, 2025Schedule 13D
Daly Joseph PatrickMay 14, 2025Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Richard C Pfenniger Jr
Other companies: Fluent, Inc. (Director · Since at least Oct 6, 2022); GeneDx Holdings Corp. (Director · Since at least Apr 29, 2022); Cocrystal Pharma, Inc. (Director · Since at least May 27, 2021); OPKO Health, Inc. (Director · Since at least Jan 24, 2008); Wright Investors' Service Holdings, Inc. (Director · Mar 31, 2015 – Oct 22, 2018 · Past); Asensus Surgical Inc (Director · Aug 24, 2007 – Aug 22, 2024 · Past); Continucare Corp (CEO and President, Director · Mar 24, 2006 – Oct 4, 2011 · Past); Ivax Corp (Director · Jan 26, 2006 – Jan 26, 2006 · Past); GP Strategies Corporation (Director · Feb 2, 2005 – Oct 14, 2021 · Past)
Director · Oct 24, 2016 – Dec 31, 2020 · Past
Glenn L Halpryn
Other companies: Niagen Bioscience, Inc. (Director · May 20, 2010 – Jul 6, 2015 · Past); Olenox Industries Inc. (Director · Apr 23, 2010 – Apr 23, 2010 · Past); Sorrento Therapeutics, Inc. (Director · Feb 5, 2010 – Feb 6, 2012 · Past); Fluent, Inc. (Director · Oct 30, 2009 – Jan 11, 2010 · Past); Castle Brands Inc (Director · Oct 11, 2008 – Mar 26, 2015 · Past)
CEO, Director · Oct 30, 2007 – Aug 29, 2008 · Past
Jay M. Moyes
Other companies: SiNtx Technologies, Inc. (Audit Committee Chair · Since at least Apr 3, 2025); Puma Biotechnology Inc (Director · Since at least Jun 14, 2022); Sera Prognostics, Inc. (Chief Financial Officer · Mar 6, 2023 – Jun 7, 2023 · Past); Achieve Life Sciences, Inc. (Director · May 31, 2022 – May 31, 2022 · Past)
Director · Since at least Jun 10, 2022
Krisztina M Zsebo
Other companies: Eiger Biopharmaceuticals Inc (Chief Executive Officer, Director · Jan 29, 2014 – Apr 6, 2015 · Past)
Director · Dec 22, 2020 – Jun 10, 2022 · Past
Marvin Slosman
Other companies: InspireMD Inc. (CEO and President, Director · Since at least Jan 23, 2024)
Director · Since at least Dec 2, 2025
Subbarao V. Uppaluri
Other companies: OPKO Health, Inc. (Director · Since at least Apr 14, 2010)
Director · Aug 11, 2016 – Aug 11, 2016 · Past
Andrew Scott BlankDirector · Since at least Sep 30, 2020
Bill FacteauPresident · Since at least Nov 4, 2026
Bill FacteauDirector · Since at least Apr 23, 2025
David McClungCFO · Since at least Oct 24, 2016
All 25 people
PersonSeat
Debby Holmes-HigginVP of Clinical · Since at least Nov 5, 2026
Derrick RomineCFO of Cardo Medical, LLC · Aug 29, 2008 – Aug 29, 2008 · Past
Edward GillisSr. VP of Devices · Since at least Dec 8, 2025
Eric DuckersChief Medical Officer · Oct 24, 2016 – Nov 2, 2020 · Past
Farhan ShahabVice President of Quality · Nov 24, 2025 – Nov 5, 2026 · Past
Fernando L FernandezDirector · Jan 13, 2018 – Sep 30, 2020 · Past
Jim AllenSince at least Nov 4, 2026
Jim L AllenDirector · Since at least Oct 18, 2023
Jonathan BrooksDirector · Oct 22, 2013 – May 10, 2016 · Past
Mikhail KvitnitskyPresident and Chief Operating, Director · Aug 29, 2008 – May 25, 2011 · Past
Miranda PetoInvestor Relations · Since at least Oct 19, 2026
Peter AltmanPresident and Chief Executive Officer · Since at least Oct 24, 2016
Rheaume Patricia A GiulianiVP, CFO & Treasurer · Sep 26, 2007 – Sep 26, 2007 · Past
Simon H. StertzerBoard Member · Since at least Oct 24, 2016
Thomas QuertermousDirector · Oct 24, 2016 – Jul 26, 2019 · Past

Open People

Log in to ask 6ix AI your own questions about BioCardia, Inc.